Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-06-14
2011-06-14
Ouspenski, Ilia (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S130100
Reexamination Certificate
active
07960515
ABSTRACT:
The present disclosure provides isolated binding molecules that bind to the human OX40R, nucleic acid molecules encoding an amino acid sequence of the binding molecules, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of making the binding molecules, pharmaceutical compositions containing the binding molecules, and methods of using the binding molecules or compositions.
REFERENCES:
patent: 2005/0191293 (2005-09-01), Deshpande et al.
patent: WO 99/42585 (1999-08-01), None
patent: WO 03/106498 (2003-12-01), None
patent: WO2006039418 (2006-04-01), None
patent: WO 2007/062245 (2007-05-01), None
Xie, F. et al., “Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues”, Tissue Antigens, vol. 67, No. 4, pp. 307-317, Apr. 2006.
Kjaergaard, J et al., “Therapeutic Efficacy of OX-40 Receptor Antibody Depends on Tumor Immunogenicity and Anatomic Site of tumor Growth”, Cancer Research, vol. 60, No. 19, pp. 5514-5521, Oct. 1, 2000.
Kjaergaard, J. et al., “Augmentation Versus Inhibition: Effects of Conjunctional Ox-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor”, Journal of Immunology, vol. 167, No. 11, pp. 6669-6677, Dec. 1, 2001.
Weinberg, A. et al., “Anti OX40 (CD134) Administration to Nonhuman Primates: Immunostimulatory Effects and Toxicokinetic Study”, Journal of Immunotherapy, vol. 29, No. 6, pp. 575-585, Nov. 1, 2006.
Brams Peter
Devaux Brigitte
Finn Rory F.
Gladue Ronald P.
Huang Haichun
Bristol--Myers Squibb Company
Dickstein & Shapiro LLP
Ouspenski Ilia
Pfizer Inc.
LandOfFree
Binding molecules to the human OX40 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Binding molecules to the human OX40 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding molecules to the human OX40 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2739833